Medtech
Shark
Tank
Shark
Tank
We connect innovative start ups and med tech industry.
MST operates as a facilitative interface between emerging enterprises in the vascular medical sector and the broader structures of industry, investment, and regulatory oversight.
Our primary objective is to enable innovative start-ups to transition from the early stages of product development toward clinically and commercially viable solutions. To this end, we provide structured access to a network of established companies, specialized investors, and domain experts who can accelerate both technical refinement and market introduction.
A further dimension of our activity lies in supporting the complex process of European Union medical device authorization, which often constitutes a critical barrier for young enterprises with limited regulatory expertise.
Through our platform, start-ups gain visibility and credibility within a field that is otherwise characterized by high entry thresholds and intense scrutiny.
While MST is headquartered in Germany, its operations are embedded within a transnational framework of professional partnerships, allowing participants to benefit from an international perspective and outreach. Our services are not confined to financial matchmaking, but extend to the strategic and procedural aspects of market integration.
This includes the orchestration of dialogues between innovators and established stakeholders, fostering both technological transfer and clinical applicability. Ultimately, MST provides the infrastructural conditions under which vascular medical start-ups can transform promising prototypes into approved, market-ready medical devices.
Our network
We are part of well connected influencers of the vascular medical space.
Vascupedia is the global learning resource for professionals in vascular medicine.
P.E.O. is the service-app for vascular webinars, conferences, podcasts and on-demand content.
STA/G is the content creation agency for the medical industry.
What we can do for you
CRO Support
Navigating the clinical approval pathway can be a formidable challenge for early-stage companies. MST provides comprehensive CRO support, ranging from the planning and submission of approval studies to their active implementation and final closure, thereby ensuring that regulatory requirements are met in a methodical and efficient manner.
Investment Support
Securing financial backing is critical for the development and scaling of medical technologies. Through our extensive network, MST introduces start-ups to specialized investment partners who possess both the resources and the sector-specific understanding to support innovation sustainably.
Pitching on Stage
Visibility within the professional community is essential for building credibility and momentum. By participating in our MedTech Shark Tank sessions at renowned congresses such as LINC, FYA, or CLI, start-ups are given the opportunity to present their technologies directly to an audience of key decision-makers and clinical experts.
Live Broadcasting
In order to extend outreach beyond physical events, MST facilitates live broadcasting opportunities in cooperation with VASCUPEDIA and PEO. This format allows start-ups to showcase their technologies to a global audience, significantly amplifying recognition and engagement.
G-DRG Expert Guidance
Even the most promising technologies require a viable reimbursement strategy to succeed in clinical practice. MST offers access to experts in the German Diagnosis-Related Groups (G-DRG) system, enabling start-ups to integrate reimbursement considerations early into their business model.
Distribution Express
Once regulatory approval has been achieved under the Medical Device Regulation (MDR), the challenge of market access comes into focus. MST assists in planning and accelerating European distribution through cooperation with experienced distribution specialists who understand the complexity of cross-border market integration.
Let’s talk
If you are a start-up in vascular medicine and would like to benefit from our services and out network, just …
reach out to us
Send an email and tell us about your business and what you expect us to do for you. It’s best if you talk about …
- Your USP
- The state of your company, regarding market entry
- The investment state of your company
- The amount of investment capital you are aiming for
Or even better …
fill out the form
Send us all the information we need in one go. We’ll reach out to you. Of course any information submitted is treated strictly confidentially.
Contact form
Who we are
Dr. Michael Lichtenberg
Interventional Angiologist, Arnsberg, Germany
Dr. Lorenzo Patrone
Interventional Radiologist, Florence, Italy
Dr. Peter Schneider
Vascular Surgeon, San Francisco, USA
Julian Rieck
Cardiovascular Innovation Expert, Ludwigshafen, Germany
On a note:
As of 26th of May 2021 the EU Medical Device Regulation is fully applicable
It aims to “establish a robust, transparent, predictable and sustainable regulatory framework for medical devices which ensures a high level of safety and health whilst supporting innovation”. It further aims “to ensure the smooth functioning of the internal market as regards medical devices, taking as a base a high level of protection of health for patients and users, and taking into account the small- and medium-sized enterprises that are active in this sector.”
But now, innovation is leaving the EU! The balance between safety and the functioning of the internal market is no longer existing, it will severely challenge Europe’s position as a location for the MedTech industry. And even worse, it will have a severe negative impact on European healthcare and patients, as modern and innovative technologies won’t be available to treat severe diseases.
The current Medical Device Regulation is against launching medical device innovation in the EU. Many start-up companies are now more likely to prioritize USA over EU for innovative technologies.
MST is here to support your vascular Start-up Technology and guide you through the MDR-process.
Interview with Michael Lichtenberg on the European medical start-up scene
Insights and strategies from Dr. Michael Lichtenberg on what it takes for MedTech startups to succeed in Europe’s complex regulatory and clinical landscape.
In this episode of the Let’s Talk Risk Podcast, host Naveen Agarwal speaks with Dr. Michael Lichtenberg about the challenges and opportunities in bringing innovative medical devices.
Congrats to Sentante
Sentante won the EU Medtech Shark Tank 2023 event! Well done and congratulations to the Lithuania based fully-robotic teleoperated system for endovascular interventions.
Past events
